The Zn-dependent deacetylase LpxC is an essential enzyme in Gram-negative bacteria, which has been validated as antibacterial drug target. Herein we report the chiral-pool synthesis of novel d- and l-proline-derived 3,4-dihydroxypyrrolidine hydroxamates and compare their antibacterial and LpxC inhibitory activities with the ones of 4-monosubstituted and 3,4-unsubstituted proline derivatives. With potent antibacterial activities against several Gram-negative pathogens, the l-proline-based tertiary amine 41g ((S)-N-hydroxy-1-(4-{[4-(morpholinomethyl)phenyl]ethynyl}benzyl)pyrrolidine-2-carboxamide) was found to be the most active antibacterial compound within the investigated series, also showing some selectivity toward EcLpxC (K = 1.4 μM) over several human MMPs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2019.03.056 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reliable Chemical Synthesis of UDP-3--[()-3-Hydroxydecanoyl]-GlcNAc: The Native Substrate of LpxC.
Org Lett
December 2024
University of Chinese Academy of Sciences, Beijing 100049, China.
Herein, we describe a reliable and efficient approach for the first chemical synthesis of biologically significant and complex 3--(-3-hydroxydecanoyl) modified uridine diphosphate -acetylglucosamine that is the native substrate of LpxC involved in the biosynthesis of the cell wall of . The synthetic protocol provides a successful example for the reliable preparation of modified nucleoside diphosphate sugar, which features judiciously selected protecting groups, the formation of pyrophosphate linkage with 5'-phosphate nucleoside as nucleophile, and the straightforward purification process.
View Article and Find Full Text PDFDesign, synthesis and evaluation of novel LpxC inhibitors containing a hydrazone moiety as Gram-negative antibacterial agents.
Eur J Med Chem
December 2024
School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, Liaoning, 110016, China. Electronic address:
LpxC inhibitors are new-type antibacterial agents developed in the last twenty years, mainly against Gram-negative bacteria infections. To enable the development of novel LpxC inhibitors with potent antibacterial activities, several series of compounds were designed and synthesized and their antibacterial activities were evaluated against E. coli ATCC25922, P.
View Article and Find Full Text PDFDevelopment of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity.
J Med Chem
October 2024
Institute of Organic Chemistry, Universität Hamburg, Martin-Luther-King-Platz 6, 20146 Hamburg, Germany.
In a fragment-based approach using NMR spectroscopy, benzyloxyacetohydroxamic acid-derived inhibitors of the bacterial deacetylase LpxC bearing a substituent to target the uridine diphosphate-binding site of the enzyme were developed. By appending privileged fragments via a suitable linker, potent LpxC inhibitors with promising antibacterial activities could be obtained, like the one-digit nanomolar LpxC inhibitor ()- [ (LpxC C63A) = 9.5 nM; (LpxC): 5.
View Article and Find Full Text PDFModulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds.
Neurochem Int
September 2024
Department of Life Science & Bioinformatics, Assam University, Silchar, 788011, Assam, India. Electronic address:
Article Synopsis
- Parkinson's disease (PD) is a major neurodegenerative disorder and recent studies link its pathogenesis to imbalances in gut microbiota, particularly involving Gram-negative bacteria and their endotoxin, lipopolysaccharide (LPS), which triggers inflammatory responses in the gut and brain.
- Recent findings suggest there is a connection between LPS, alpha-synuclein, and toll-like receptor 4 (TLR4), indicating a mechanism that might exacerbate inflammation and neurodegeneration in PD, warranting further research.
- The review highlights the potential of plant-derived compounds as safer alternatives to current treatments, mentioning their ability to inhibit LpxC and TLR4, with promising results seen from compounds like curcumin and juglan
Dual function of LapB (YciM) in regulating lipopolysaccharide synthesis.
Proc Natl Acad Sci U S A
April 2024
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
Levels of lipopolysaccharide (LPS), an essential glycolipid on the surface of most gram-negative bacteria, are tightly controlled-making LPS synthesis a promising target for developing new antibiotics. adaptor protein LapB (YciM) plays an important role in regulating LPS synthesis by promoting degradation of LpxC, a deacetylase that catalyzes the first committed step in LPS synthesis. Under conditions where LPS is abundant, LapB recruits LpxC to the AAA+ protease FtsH for degradation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!